Related references
Note: Only part of the references are listed.Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
Marta Lopez-Fauqued et al.
VACCINE (2019)
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
Kathleen L. Dooling et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
Roman Chlibek et al.
VACCINE (2014)
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
Roman Chlibek et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
THE GLOBAL EPIDEMIOLOGY OF HERPES ZOSTER
Barbara P. Yawn et al.
NEUROLOGY (2013)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
MN Oxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)